Type a product name, treatment, or category.
A once-weekly prescription treatment containing tirzepatide, available following an individual clinical assessment.
Mounjaro is a prescription weight-management medicine containing the active ingredient tirzepatide.
It acts on two natural hormone pathways involved in appetite and blood-sugar regulation. This may help reduce hunger, increase feelings of fullness and reduce food cravings.
Mounjaro is injected once a week and should be used alongside appropriate dietary changes, regular physical activity and ongoing clinical support.
Completing an assessment does not guarantee that Mounjaro will be prescribed or supplied. Treatment is approved only when it is considered clinically appropriate.
Mounjaro acts on two hormone pathways involved in appetite, digestion and blood-sugar regulation.
Mounjaro may reduce feelings of hunger, making it easier for some patients to follow an appropriate eating plan.
Treatment may increase feelings of fullness after eating and support a reduction in overall food intake.
By influencing appetite-related signals, Mounjaro may reduce the frequency or intensity of food cravings.
Mounjaro may be considered for adults with a BMI of 30 kg/m² or above, or a BMI from 27 kg/m² to below 30 kg/m² together with at least one weight-related health condition.
General criteria are only the starting point. The pharmacist must review your complete health profile before deciding whether treatment is appropriate.
Check My SuitabilityMounjaro is administered once weekly using a pre-filled KwikPen. Always follow the patient leaflet and the instructions provided by your pharmacist.
Each Mounjaro KwikPen contains four weekly doses. A new compatible needle should be used for every injection.
Use Mounjaro once a week, preferably on the same day each week. It may be taken at any time of day, with or without food.
Read the supplied instructions before use. Attach a new compatible needle and prepare the pen exactly as directed.
Inject under the skin of the abdomen, thigh or upper arm. Rotate the injection site rather than using the same area repeatedly.
Remove the needle after every injection and place it in an appropriate sharps container. Store the pen as instructed.
Never share your Mounjaro KwikPen or needles with another person. Needles are not included with the pen. Contact the pharmacist when you are unsure how to prepare, inject or store your treatment.
Mounjaro can cause side effects and is not suitable for everyone. Review the important information below and provide complete, accurate answers during your assessment.
Commonly reported effects may include nausea, diarrhoea, vomiting, constipation, abdominal discomfort, indigestion, bloating, reduced appetite, fatigue and injection-site reactions.
Eating smaller meals, avoiding rich or high-fat foods and maintaining adequate hydration may help reduce digestive discomfort.
Take it as soon as you remember, then continue with your next injection on the normal weekly treatment day.
Do not take the missed injection. Take your next dose on the normal scheduled day.
Mounjaro should not be used during pregnancy. Tell the pharmacist if you are pregnant, think you may be pregnant or are planning pregnancy.
Tell the pharmacist if you are breastfeeding or planning to breastfeed before requesting treatment.
An additional barrier method or a non-oral contraceptive method may be advised for four weeks after starting Mounjaro and for four weeks after every dose increase.
Provide complete details about your health conditions, prescription medicines, non-prescription treatments and previous reactions.
Stop using Mounjaro and seek urgent help when serious or rapidly worsening symptoms occur.
Do not increase, reduce or stop treatment without appropriate professional guidance. Contact the pharmacist when symptoms are persistent, worsening or difficult to manage.
Complete a confidential assessment and allow a pharmacy professional to review your health, current medicines and treatment suitability.
Provide accurate information about your health history, medicines, allergies, height, weight and previous treatments.
Confidential online formYou may be asked for identification, recent photographs, medication evidence or additional clinical information.
Secure verificationA qualified pharmacy professional reviews your information and may contact you when further details are required.
Individual clinical reviewTreatment may be approved, changed, delayed while further information is requested, or declined where it is unsuitable.
Responsible prescribingStart the confidential assessment and provide the information required for an individual pharmacist review.
Previous use, payment or completion of a consultation does not guarantee that Mounjaro will be prescribed or supplied.
Find clear answers about weekly use, dose progression, switching treatments, pregnancy and the clinical approval process.
Yes. Mounjaro is normally injected once weekly, preferably on the same day each week. It may be taken at any time of day, with or without food.
The usual adult starting dose is 2.5 mg once weekly for four weeks. Treatment is then normally increased to 5 mg once weekly. Any further increase requires clinical approval.
No. Not every patient needs or tolerates the maximum dose. Your prescriber will consider your response, side effects and clinical needs before recommending any dose increase.
Results vary between patients and cannot be guaranteed. Progress depends on individual response, treatment adherence, eating habits, physical activity, health conditions and other personal factors.
A switch may be considered following a new clinical assessment. Never combine or switch weight-management medicines without guidance from your prescriber.
No. Mounjaro should not be used during pregnancy. Tell the pharmacist if you are pregnant, planning pregnancy or think you may be pregnant.
The pharmacist may recommend another treatment, ask for additional medical information or advise you to contact your GP or another appropriate healthcare service.
No. Mounjaro is supplied only after the pharmacist confirms that it is clinically suitable, appropriate and safe for you.
Complete a confidential online assessment and let our pharmacy professional review whether Mounjaro may be suitable for your health, circumstances and weight-management goals.